Efficacy, Immunogenicity and Safety of COVID-19 Vaccine , Inactivated in Children and Adolescents

NCT04992260 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
11349
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sinovac Research and Development Co., Ltd.